Pharma Companies

Pharmaceuticals Export Promotion Council of India (Pharmexcil), under the Ministry of Commerce and Industry, told News18 that Indian pharma companies are currently reluctant to ship items to Bangladesh over unpaid dues.

NMC puts on hold its regulations mandating doctors to prescribe generic drugs, bar them from endorsing any drug brand

They said the regulation barring doctors from attending conferences sponsored by pharma companies warrants reconsideration and also demanded that associations and organisations should be exempted from the purview of NMC guidelines.

Mandaviya bats for self-regulation by small pharma firms, says won’t compromise on drug quality

Mandaviya directed the Drugs Controller General of India (DCGI) to take stringent action against all pharmaceutical manufacturing companies involved in manufacturing of spurious drugs.

Pharma companies take FDC drugs off shelves after central govt ban

Sales of Rs 807 crore will be hit due to the ban on 14 FDCs announced last week. A majority of the cocktail drugs are from the respiratory segment.

As govt readies plans to test drugs before export, industry stresses on quality management

To check adulteration, the health ministry has started deliberations on testing drugs prior to export. However, the pharma industry has called for strengthening drug quality management and eschewing over-reliance on testing

Got Rs 10 lakh to invest? Tata MF’s fund manager picks 3 mutual funds to ride out volatile markets

A recession in global markets, especially in the US, might actually be a good news for India, as the domestic Information Technology sector could win some outsourcing contracts that were earlier for US-based companies, says Tata Mutual Fund’s Meeta Shetty

Growth drivers are finally falling in place for large pharma companies

Analysts project a notable improvement in revenue growth rates at Sun Pharma, Dr Reddy’s Labs, Cipla vis-à-vis FY17-22

'Freebies' to doctors: Pharma industry lobby seeks new code to regulate marketing interaction

The structure of interaction between pharma companies and doctors should be defined by the government, industry groups say. The Centre had earlier said the existing Universal Code of Pharmaceutical Marketing Practices worked adequately.

Govt Forms Panel to Review Marketing Practices of Pharma Firms, Sets 90-day Cut-off for Report

The five-member panel will be led by Dr VK Paul, member (health) at NITI Aayog as its chairman.

Mansukh Mandaviya asks pharma industry to tackle spurious drug menace

Out of 84,874 samples tested by various drug controllers, up to 2,652 samples were not of standard quality last year, the Centre informed Parliament in July.

Rise in essential drug prices may not boost pharma earnings significantly

Raw material inflation continues to be a problem for drug manufacturers, eroding the benefit from an increase in the prices of essential drugs

Pharma companies turn to acquisitions to build scale, gain an edge

Pharma companies are reorganising themselves, by focusing on select products lines, regions and exiting non-core assets

India remains a bright spot for pharma companies

US business continues to face pricing pressures while latest data indicate a recovery taking hold in the Indian pharmaceutical market

Coronavirus impact| Pharma companies to see earnings growth: Aditya Khemka, DSP MF

He, however, said currency, competition and regulations pose risks to the sector

Indian pharma sector's growth slips to 7.6% in January, anti-diabetes segment a drag

The patents for Vildagliptin in India, held by Novartis, expired on December 9, opening the market for cheap rip-offs.

Reporter's Take | More problems for Lupin as USFDA cautions company

Moneycontrol's Shraddha Sharma gets in conversation with Viswanath Pilla to find out the impact of the USFDA warning on the company.

Reporter's Take | How safe are generic drugs?

Moneycontrol’s Shraddha Sharma talks to Viswanath Pilla to know more about the debate and if there are solutions to it.

Proposed cap on trade margins will not hurt pharma cos: Fitch

"India's proposal to cap trade margins...will not significantly hurt the profitability of pharmaceutical companies, as the proposal does not restrict the margins at which pharma companies sell to distributors," Fitch said in a statement.

Reporter's Take | India's job market looks strong in 2019

According to the India Salary Benchmark 2019 report there will be increased demand for senior executives equipped with business and stakeholder management experience.

Indian pharma cos should partner Chinese manufacturers for greater market access: Study

The research study on ‘Enhancing Indian exports of pharmaceutical products to China' has suggested as many as 17 options to domestic firms for gaining market access in China. It was commissioned by the ministry.

How the US regulator's import ban has pushed Divis off its pedestal

The company that earlier maintained a clean regulatory track record failed spectacularly in the US FDA's audit last December.

CEOs of pharma cos to discuss key challenges within industry

CEOs of leading pharma companies will meet to discuss key challenges within the industry on the sidelines of the 10th edition of CPhI India exhibition here, beginning November 21.

Scrapping Obamacare would hit most pharma cos: Jeff Chowdhry

Scrapping of Obamacare is sure to impact pharma companies both globally and Indian, said Jeff Chowdhry, Senior Portfolio Manager, LGM Investments.

e-Pharmacy to Provide Growth Opportunities for Pharma Companies and Last Mile Access of Medicines to Patients, Finds Frost & Sullivan

The Federation of Indian Chambers of Commerce and Industry (FICCI) — an apex business organization — in association with Frost & ...

IPA files contempt petition against NPPA

As far as the petition goes, the IPA has said that the NPPA has committed a contempt of court order with regard to the August 2014 order of the Bombay High Court where they said that no coercive action should be taken against any pharma company belonging to the IPA.